Monday, November 16, 2026Every story links to its original source.

Genome News

Genomics news, traced to the source.

Reading

On This Day in Genomics

Genome sequencing linked 26 MRSA cases to a Cambridge baby unit outbreak

Whole-genome sequencing linked 26 cases of MRSA carriage to an outbreak on a special care baby unit at a National Health Service Foundation Trust in Cambridge, UK. Harris and colleagues published the work in Lancet Infectious Diseases on 14 November 2012. Over six months in 2011, the hospital's infection-control team had found 12 infants colonised with MRSA, meaning they carried the bacterium, and suspected the cases were connected. Conventional methods could not confirm a persistent outbreak. Sequencing could. It showed transmission inside the unit and in the community, as well as between mothers on a postnatal ward.

MRSA stands for meticillin-resistant Staphylococcus aureus, a form of Staphylococcus aureus that resists the antibiotic meticillin. Some strains can persist in the community and replace the MRSA lineages adapted to hospitals. Because of that, the authors argued that hospital and community have to be studied as one entity.

The infection-control team had relied on epidemiological data, which track who was where and when. It also used antibiograms, which show the pattern of antibiotics a sample resists. Whole-genome sequencing reads the complete DNA of each bacterial sample, or isolate. The authors used it to check and extend the team's findings. They sequenced isolates from all colonised patients on the unit. They also sequenced MRSA from patients elsewhere in the hospital or in the community whose bacteria shared the outbreak strain's antibiotic susceptibility profile.

The strain turned out to be new. It was labelled sequence type (ST) 2371 and is closely related to ST22, but it carries genes for Panton-Valentine leucocidin, a toxin. The outbreak had kept going through stretches when no infection was known on the unit, and even after a deep clean. Working from the sequencing data, the authors proposed, and then confirmed, that a staff member carrying MRSA had allowed it to persist.

This was a descriptive study of one outbreak at one hospital trust. The authors wrote that whole-genome sequencing "holds great promise for rapid, accurate, and comprehensive identification of bacterial transmission pathways in hospital and community settings." They tied that promise to reductions in infections, morbidity and costs, but the study did not measure any of those outcomes. Funding came from the UK Clinical Research Collaboration Translational Infection Research Initiative, the Wellcome Trust, the Health Protection Agency and the National Institute for Health Research Cambridge Biomedical Research Centre.

Sources

Back to today in history · Browse the archive